Abstract
BackgroundCT-P47 is a recombinant humanized monoclonal antibody that was developed as a proposed biosimilar of tocilizumab.ObjectivesThe purpose of this study was to compare the pharmacokinetics (PK), safety, and immunogenicity of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
